NeoGenomics, Inc. (NEO)
NASDAQ: NEO · Real-Time Price · USD
9.02
+0.41 (4.76%)
At close: Apr 28, 2026, 4:00 PM EDT
9.00
-0.02 (-0.22%)
After-hours: Apr 28, 2026, 4:45 PM EDT

NeoGenomics Market Cap

NeoGenomics has a market cap or net worth of $1.17 billion as of April 28, 2026. Its market cap has increased by 2.68% in one year.

Market Cap
1.17B
Enterprise Value
1.42B
1-Year Change
2.68%
Ranking
Category
Stock Price
$9.02

Market Cap Chart

Since March 16, 2004, NeoGenomics's market cap has increased from $7.90M to $1.17B, an increase of 14,759.46%. That is a compound annual growth rate of 25.36%.

History

DateMarket Cap% Change
Apr 27, 20261.12B-26.54%
Dec 31, 20251.52B-28.07%
Dec 31, 20242.12B2.57%
Dec 29, 20232.06B76.73%
Dec 30, 20221.17B-72.22%
Dec 31, 20214.20B-29.72%
Dec 31, 20205.98B95.74%
Dec 31, 20193.05B160.37%
Dec 31, 20181.17B64.64%
Dec 29, 2017712.40M5.87%
Dec 30, 2016672.90M41.66%
Dec 31, 2015475.00M89.92%
Dec 31, 2014250.10M41.06%
Dec 31, 2013177.30M57.88%
Dec 31, 2012112.30M85.62%
Dec 30, 201160.50M24.49%
Dec 31, 201048.60M-12.90%
Dec 31, 200955.80M189.12%
Dec 31, 200819.30M-43.07%
Dec 31, 200733.90M-16.30%
Dec 29, 200640.50M841.86%
Dec 30, 20054.30M-20.37%
Dec 31, 20045.40M-31.65%
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Twist Bioscience 3.63B
BillionToOne 3.58B
Veracyte 2.66B
GRAIL 2.16B
GeneDx Holdings 1.94B
CareDx 1.12B
OPKO Health 922.27M
Castle Biosciences 748.92M
Market Cap Rankings